Growth Metrics

Mannkind (MNKD) Equity Average (2011 - 2026)

Mannkind (MNKD) reported Equity Average of -$55.1 million for Q1 2026, up 19.8% year-over-year from -$46.0 million in Q1 2025, and down 15.32% on a QoQ basis from -$47.8 million in Q4 2025.

Mannkind (MNKD) has 16 years of Equity Average data on file, last reported at -$55.1 million in Q1 2026.

  • Quarterly Equity Average rose 19.8% year-over-year to -$55.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.1 million (up 19.8% YoY) and the FY2025 annual result came in at -$64.9 million, up 60.05% from the prior year.
  • Equity Average fell to -$55.1 million in Q1 2026 per MNKD's latest filing, from -$47.8 million in the prior quarter.
  • Across five years, Equity Average topped out at -$47.8 million in Q4 2025 and bottomed at -$257.9 million in Q2 2023.
  • The 5-year median for Equity Average is -$227.9 million (2024), against an average of -$180.5 million.
  • The widest annual swing landed in 2022, when Equity Average slumped 34.14%; it then soared 77.14% in 2025.
  • Tracing MNKD's Equity Average over 5 years: stood at -$244.1 million in 2022, then decreased by 1.99% to -$249.0 million in 2023, then soared by 42.01% to -$144.4 million in 2024, then soared by 66.9% to -$47.8 million in 2025, then declined by 15.32% to -$55.1 million in 2026.
  • Per Business Quant, the three latest MNKD Equity Average figures stand at -$55.1 million (Q1 2026), -$47.8 million (Q4 2025), and -$49.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.76 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.01 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.34 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 932.28 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -55.11 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -55.11 Mn
Dec 31, 2025 -47.79 Mn
Sep 30, 2025 -49.80 Mn
Jun 30, 2025 -56.83 Mn
Mar 31, 2025 -68.72 Mn
Dec 31, 2024 -144.37 Mn
Sep 30, 2024 -217.85 Mn
Jun 30, 2024 -227.88 Mn
Mar 31, 2024 -238.07 Mn
Dec 31, 2023 -248.97 Mn
Sep 30, 2023 -256.13 Mn
Jun 30, 2023 -257.94 Mn
Mar 31, 2023 -252.97 Mn
Dec 31, 2022 -244.11 Mn
Sep 30, 2022 -242.37 Mn
Jun 30, 2022 -239.56 Mn
Mar 31, 2022 -220.71 Mn
Dec 31, 2021 -197.02 Mn
Sep 30, 2021 -184.12 Mn
Jun 30, 2021 -178.59 Mn
Mar 31, 2021 -177.02 Mn
Dec 31, 2020 -183.42 Mn
Sep 30, 2020 -183.07 Mn
Jun 30, 2020 -188.88 Mn
Mar 31, 2020 -194.29 Mn
Dec 31, 2019 -187.62 Mn
Sep 30, 2019 -190.35 Mn
Jun 30, 2019 -192.00 Mn
Mar 31, 2019 -181.54 Mn
Dec 31, 2018 -190.26 Mn
Sep 30, 2018 -206.03 Mn
Jun 30, 2018 -214.91 Mn
Mar 31, 2018 -218.97 Mn
Dec 31, 2017 -232.87 Mn
Sep 30, 2017 -236.13 Mn
Jun 30, 2017 -209.98 Mn
Mar 31, 2017 -191.16 Mn
Dec 31, 2016 -211.14 Mn
Sep 30, 2016 -302.63 Mn
Jun 30, 2016 -370.02 Mn
Mar 31, 2016 -361.90 Mn
Dec 31, 2015 -237.45 Mn
Sep 30, 2015 -120.02 Mn
Jun 30, 2015 -106.25 Mn
Mar 31, 2015 -85.40 Mn
Dec 31, 2014 -57.22 Mn
Sep 30, 2014 -43.53 Mn
Jun 30, 2014 -14.42 Mn
Mar 31, 2014 -6.59 Mn
Dec 31, 2013 -99.22 Mn
Sep 30, 2013 -160.04 Mn
Jun 30, 2013 -149.58 Mn
Mar 31, 2013 -128.74 Mn
Dec 31, 2012 -193.46 Mn
Sep 30, 2012 -260.31 Mn
Jun 30, 2012 -260.88 Mn
Mar 31, 2012 -295.52 Mn
Dec 31, 2011 -297.23 Mn
Sep 30, 2011 -263.10 Mn